Table 4.
# | IC50 nMa | Solubilityb (μM) |
cLogPc | Microsomal stability (%)d NADPH |
|
---|---|---|---|---|---|
− | + | ||||
3a | 15.6 ± 0.7 | 75 < S < 100 | 4.24 | 97 ± 4 | 0.4 ± 0.2 |
4a | 28.8 ± 4.5 | 125 < S < 150 |
4.50 | 115 ± 11 | 0.4 ± 0.2 |
3b | 12.5 ± 1.8 | 100< S < 125 | 3.85 | 87 ± 6 | 0.8 ± 0.2 |
4b | 18.0 ± 2.9 | 25 < S < 50 | 3.89 | 102 ± 11 | 0.4 ± 0.3 |
3c | 4.9 ± 0.1 | 75 < S < 100 | 2.59 | 91 ± 8 | 0.4 ± 0.1 |
4c | 4.8 ± 0.6 | 75 < S < 100 | 2.63 | 95 ± 1 | 0.3 ± 0.1 |
3d | 9.9 ± 2.9 | 450 < S < 475 | 2.36 | 72 ± 4 | 2.9 ± 0.5 |
4d | 111.1 ± 10.3 | 200 < S < 225 |
2.62 | 83 ± 3 | 0.1 ± 0.1 |
3g | 13.7 ± 3.0 | 75 < S < 100 | 3.91 | 97 ± 10 | 0.3 ± 0.1 |
4g | 14.2 ± 2.5 | 75 < S < 100 | 4.17 | 92 ± 6 | 0.4 ± 0.1 |
As determined via a kinetic fluorescent assay.34, 35 Results are average ± standard deviation of three separate measurement.
Solubility was measured in sodium phosphate buffer (pH 7.4, 0.1 M) containing 1% of DMSO.
Calculated using ChemBioDraw Ultra v12.0 (PerkinElmer, Waltham, MA).
Percent of compound (1 μM) remaining after 30 minutes incubation with human liver microsomes (1 mg/mL) at 37°C with or without NADPH generating system. Results are the average of triplicates ± standard deviation.